Related content

Azacitidine for treatment of patients with myelodysplastic syndromes (MDS): practical recommendations of the German MDS Study Group

By Götze Katharina   Platzbecker Uwe   Giagounidis Aristoteles   Haase Detlef   Lübbert Michael   Aul Carlo   Ganser Arnold   Germing Ulrich   Hofmann Wolf-Karsten  

Annals of Hematology, Vol. 89, Iss. 9, 2010-09 ,pp. : 841-850

Springer Publishing Company

Access to resources Recommend Favorite

Challenges in heart transplantation: now and the future

By Gambino A.  

Transplantation Proceedings, Vol. 35, Iss. 8, 2003-12 ,pp. : 3069-3071

Elsevier

Access to resources Recommend Favorite

Current Molecular Understanding and Future Treatment Strategies for Pathologic Ocular Neovascularization

By  

Current Molecular Medicine, Vol. 9, Iss. 8, 2009-11 ,pp. : 973-981

Bentham Science Publishers

Access to resources Recommend Favorite

A limited number of 5-azacitidine cycles can be effective treatment in MDS

By Müller-Thomas Catharina   Schuster Tibor   Peschel Christian   Götze Katharina  

Annals of Hematology, Vol. 88, Iss. 3, 2009-03 ,pp. : 213-219

Springer Publishing Company

Access to resources Recommend Favorite

Comparison of peak and trough level monitoring of cyclosporine treatment using two modern cyclosporine preparations

By Durlik M.   Rauch C.   Thyroff-Friesinger U.   Streu H.   Paczek L.  

Transplantation Proceedings, Vol. 35, Iss. 4, 2003-06 ,pp. : 1304-1307

Elsevier

Access to resources Recommend Favorite